Who owns the BYCEMMA trademark?

The BYCEMMA trademark is owned by Amgen Inc..

What class is the BYCEMMA trademark registered in?

The BYCEMMA trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for BYCEMMA?

The USPTO serial number for BYCEMMA is 88783462.

What is the registration number for BYCEMMA?

BYCEMMA is registered under USPTO registration number 0.

Sealvo

Home Search: BYCEMMABYCEMMA #88783462

Back

Updated Oct 14, 2026·34 searches this week

View on USPTO TSDR Find similar marks

BYC

USPTO Trademark Record

ABANDONED

BYCEMMA

SN 88783462·Reg 0·Filed Feb 03, 2020

Owner Amgen Inc.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

BYCEMMA (Serial No. 88783462), Registration No. 0, is a abandoned US trademark filed on Feb 03, 2020 by Amgen Inc.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

Mark Intelligence

BYCEMMA (Reg. #0) is an abandoned US trademark that was filed in 2020 but has since been abandoned. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Feb 03, 2020

SERIAL

88783462

REG#

Filing Information

StatusABANDONED

Filing DateFeb 03, 2020

Serial Number88783462

Registration No.0

Status DateJul 04, 2022

Published for OppositionOct 06, 2020

Mark TypeStandard characters

Filing Basis & Declarations

Standard Characters ClaimedTrademark

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 006, 018, 044, 046, 051, 052

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

25 events

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Jul 05, 2022

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

ABANDONMENT - NO USE STATEMENT FILED

Jul 04, 2022

ABANDONMENT - NO USE STATEMENT FILED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Sep 18, 2021

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

Sep 16, 2021

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 2 FILED

Sep 16, 2021

SOU EXTENSION 2 FILED

SOU EXTENSION 2 GRANTED

Sep 16, 2021

SOU EXTENSION 2 GRANTED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

May 06, 2021

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

May 04, 2021

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 1 FILED

May 04, 2021

SOU EXTENSION 1 FILED

SOU EXTENSION 1 GRANTED

May 04, 2021

SOU EXTENSION 1 GRANTED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Dec 01, 2020

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Oct 06, 2020

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

PUBLISHED FOR OPPOSITION

Oct 06, 2020

PUBLISHED FOR OPPOSITION

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Sep 16, 2020

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Aug 28, 2020

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS/EMAIL CORRESPONDENCE ENTERED

Aug 27, 2020

TEAS/EMAIL CORRESPONDENCE ENTERED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Aug 27, 2020

CORRESPONDENCE RECEIVED IN LAW OFFICE

ASSIGNED TO LIE

Aug 25, 2020

ASSIGNED TO LIE

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Aug 04, 2020

TEAS RESPONSE TO OFFICE ACTION RECEIVED

ASSIGNED TO EXAMINER

Mar 11, 2020

ASSIGNED TO EXAMINER

NON-FINAL ACTION WRITTEN

Mar 11, 2020

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Mar 11, 2020

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Mar 11, 2020

NOTIFICATION OF NON-FINAL ACTION E-MAILED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Feb 07, 2020

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Feb 06, 2020

NEW APPLICATION ENTERED

Other Marks by Amgen Inc.

Additional USPTO filings from the same owner.

FRA

FRACTURE CARE GAP PRIORITIZING OSTEOPOROSIS CARE

99440773

Amgen Inc.

REGISTERED

AVS

AVSOLA

87906185

Amgen Inc.

REGISTERED

LIP

LIPID LINK

88347192

Amgen Inc.

REGISTERED

LOG

LogoMark

86763413

Amgen Inc.

REGISTERED

Other Marks by Timothy J. Gaul

Additional USPTO filings handled by the same attorney of record.

AMG

AMGENEDGE

90533084

REGISTERED

HEA

HEART FAILURE LINK

88698095

REGISTERED

AMG

AMGEN EDGE

87624569

ABANDONED

DBI

DBITE

90792452

ABANDONED

BYCEMMA

Run a conflict check

Other Marks by Amgen Inc.

Other Marks by Timothy J. Gaul

Get pre-filing clearance

Search 14M+ trademarks

Resources

Company